Alba Therapeutics

Latest Headlines

Latest Headlines

Biotech vets back $22M A round for neuroscience startup

The former CEO of Alba Therapeutics, Blake Paterson, has put together a $22 million A round to launch his new biotech in Baltimore.

Advanced Viral Research runs out of cash

Advanced Viral Research says that it will suspend operations after running out of cash and failing to raise new money. The 22-year-old company has two programs in mid-stage development--AVR-118 and